Drugs / lyophilized black raspberries
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01469429 | Sep 2007 → Sep 2014 | carcinoma in situ of hypopharynx, carcinoma in situ of nasopharynx, carcinoma in situ of oropharynx, hypopharynx squamous cell carcinoma +10 | Ohio State University Comprehensive Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lyophilized black raspberries | “Patients receive lyophilized black raspberries lozenge PO QID.” NCT01469429 ↗ |
| Route | Oral | “Receive LBR lozenge PO” NCT01469429 ↗ |